MarketInOut Stock Screener Log In | Sign Up

Nyxoah S.A.

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
Nyxoah S.A. stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization92.76 mln
Float81.29 mln
Earnings Date11/05/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-1.35
Manipulation likely

1-Year Forecast

2.78
Transformational upside

Relative Strength

6 / 100
Severely lagging

Debt / Equity

0.72
Moderate leverage

Pre-Tax Margin

-436%
Severely loss-making

Business Description

Founded in Belgium in 2009, Nyxoah SA focuses on improving the lives of people who suffer from moderate to severe obstructive sleep apnea. Its flagship product, the Genio system, stimulates a nerve in the tongue to keep the airway open during sleep, requiring only a small surgical procedure. The device has received CE Mark approval, reflecting its safety and effectiveness for patients across Europe.

Key Fundamentals

EPS-2.33
ROE-164
RPS0.44
ROIC-109
ROA-80.73
Interest Cover-5.73
EBITDA, mln-95.94
EV / EBITDA-0.28
EV / EBIT-0.26
Revenue, mln25.25
EV / Revenue1.05

Quote Details

Last 0.8715
Change -0.0164 (-1.85%)
Open 0.877
Volume 157,839
Turnover 137,557
Average Volume 231,908

Financial Ratios

Pre-Tax Profit Margin-436
Leverage Ratio2.03
Current Ratio2.37
Price / Book1.49
Price / Tangible Book3.51
Debt / Equity0.72
Price / Sales2.61

Financial Strength

Altman Z-Score-3.08
Piotroski F-Score 3 / 9
Beneish M-Score-1.35
1-Year Target Price2.78
Short Ratio0.57
Short % of Float0.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.45% 87 / 100   
1 Month -34.47% 9 / 100   
2 Months -37.75% 12 / 100   
6 Months -70.95% 6 / 100   
1 Year -82.91% 8 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog